Melissa A Valerio-Shewmaker
Overview
Explore the profile of Melissa A Valerio-Shewmaker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Messiah S, Abbas R, Bergqvist E, Kohl 3rd H, Swartz M, Talebi Y, et al.
Front Pediatr
. 2024 Sep;
12:1393321.
PMID: 39228441
Background: Understanding the distinct immunologic responses to SARS-CoV-2 infection among pediatric populations is pivotal in navigating the COVID-19 pandemic and informing future public health strategies. This study aimed to identify...
2.
Dias E, Padilla J, Cuccaro P, Walker T, Balasubramanian B, Savas L, et al.
BMC Health Serv Res
. 2024 Jul;
24(1):797.
PMID: 38987761
Background: There is an urgent need to increase colorectal cancer screening (CRCS) uptake in Texas federally qualified health centers (FQHCs), which serve a predominantly vulnerable population with high demands. Empirical...
3.
DeSantis S, Yaseen A, Hao T, Leon-Novelo L, Talebi Y, Valerio-Shewmaker M, et al.
Open Forum Infect Dis
. 2023 Dec;
10(12):ofad564.
PMID: 38099238
No abstract available.
4.
DeSantis S, Yaseen A, Hao T, Leon-Novelo L, Talebi Y, Valerio-Shewmaker M, et al.
J Infect Dis
. 2023 Feb;
227(10):1164-1172.
PMID: 36729177
Background: Breakthrough infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are well documented. The current study estimates breakthrough incidence across pandemic waves, and evaluates predictors of breakthrough and severe...
5.
Valerio-Shewmaker M, Heredia N, Pulicken C, Mathews P, Chenier R, Swoboda T, et al.
Front Public Health
. 2022 Dec;
10:928148.
PMID: 36504969
Background: Despite the availability of multilevel evidence-based interventions for blood pressure management, poor hypertension control is common among community health center patient populations across the state of Texas and the...
6.
DeSantis S, Leon-Novelo L, Swartz M, Yaseen A, Valerio-Shewmaker M, Talebi Y, et al.
PLoS One
. 2022 Sep;
17(9):e0273694.
PMID: 36084125
Accurate estimates of natural and/or vaccine-induced antibodies to SARS-CoV-2 are difficult to obtain. Although model-based estimates of seroprevalence have been proposed, they require inputting unknown parameters including viral reproduction number,...
7.
Weerakoon S, Henson-Garcia M, Valerio-Shewmaker M, Messiah S, Knell G
JMIR Form Res
. 2022 Jul;
6(8):e38076.
PMID: 35878123
Background: Large-scale health communication challenges during the COVID-19 pandemic, such as widespread misinformation and distrust in health care professionals, have influenced reluctance to take the COVID-19 vaccine, also known as...
8.
Swartz M, DeSantis S, Yaseen A, Brito F, Valerio-Shewmaker M, Messiah S, et al.
J Infect Dis
. 2022 May;
227(2):193-201.
PMID: 35514141
Understanding the duration of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that causes COVID-19 is important to controlling the current pandemic. Participants from the Texas Coronavirus...
9.
Messiah S, DeSantis S, Leon-Novelo L, Talebi Y, Brito F, Kohl H, et al.
Pediatrics
. 2022 Mar;
149(6).
PMID: 35301530
No abstract available.
10.
Valerio-Shewmaker M, DeSantis S, Swartz M, Yaseen A, Gonzalez M, Kohl H, et al.
Front Public Health
. 2021 Dec;
9:753487.
PMID: 34970525
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and immunity remains uncertain in populations. The state of Texas ranks 2nd in infection with over 2.71 million cases and has seen...